LONDON, June 10 – British pharmaceutical giant GSK has agreed to acquire US biotechnology company Nuvalent for US$10.6 billion, strengthening…
LONDON, June 10 – British pharmaceutical giant GSK has agreed to acquire US biotechnology company Nuvalent for US$10.6 billion, strengthening…